In 2019, France identified bioproduction as a strategic axis for the next ten years in order to ensure health independence with the innovative products of tomorrow. This desire has been manifested by numerous national initiatives, within the framework of the Strategic Contract of Sector Industries and Health Technologies (CSF ITS), the work of the LEEM, by the appointment of a Grand Défi Biomédicaments, etc. The strategic need for a strong industrial basis in bioproduction has also been highlighted by the crisis we are going through with COVID-19, which has revealed France’s strong health dependency. In this context, Medicen Paris Région and Polepharma have decided to join forces to co-organize the 5th Edition of the Bioproduction Congress, renamed as the France Bioproduction Congress (#CFB21), in order to bring together and federate all the players in the health and bioproduction sectors.
Polepharma and Medicen will meet you on June 17 and 18, 2021 at the Palais des Congrès in Tours.
More information about the event following this link.